<DOC>
	<DOCNO>NCT01764789</DOCNO>
	<brief_summary>This pilot clinical trial study stress reduction improving quality life patient recurrent gynecologic breast cancer . Participating stress reduction program may help improve quality life patient gynecologic breast cancer .</brief_summary>
	<brief_title>Stress Reduction Improving Quality Life Patients With Recurrent Gynecologic Breast Cancer</brief_title>
	<detailed_description>PRIMARY OBJECTIVES : I . To refine intervention . II . Test acceptability , feasibility , clinical appropriateness intervention . III . To provide preliminary test efficacy . OUTLINE : Patients participate multi-component intervention base cognitive behavioral principle comprise mindfulness-based stress reduction ( MBSR ) , intervention promote hopefulness , problem solve approach navigates around obstacle generates alternative goal become block . Additional topic may cover indicated clinical need patient goal . Biobehavioral component include address social disease-specific quality life , pain education . Intensive treatment session continue weekly 16 week follow 2 biweekly 2 monthly maintenance session . After completion study treatment , patient follow 28 week .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Sarcoma</mesh_term>
	<mesh_term>Anxiety Disorders</mesh_term>
	<mesh_term>Uterine Cervical Neoplasms</mesh_term>
	<mesh_term>Fatigue</mesh_term>
	<mesh_term>Neoplasms , Germ Cell Embryonal</mesh_term>
	<mesh_term>Neoplasms , Glandular Epithelial</mesh_term>
	<mesh_term>Ovarian Neoplasms</mesh_term>
	<mesh_term>Fallopian Tube Neoplasms</mesh_term>
	<mesh_term>Endometrial Neoplasms</mesh_term>
	<mesh_term>Germinoma</mesh_term>
	<mesh_term>Vulvar Neoplasms</mesh_term>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Vaginal Neoplasms</mesh_term>
	<mesh_term>Trophoblastic Neoplasms</mesh_term>
	<mesh_term>Gestational Trophoblastic Disease</mesh_term>
	<mesh_term>Pseudomyxoma Peritonei</mesh_term>
	<mesh_term>Leydig Cell Tumor</mesh_term>
	<criteria>Diagnosis recurrent breast gynecologic cancer ( site ) diseasefree interval ; second primary cancer meet criterion English speaking Able willing give inform consent To consider blood saliva collection , woman must fulfill follow secondary criterion : Diagnosis recurrent breast ovarian cancer diseasefree interval Residence &gt; 70 mile research site Subnormal intellectual potential ( diagnosis mental retardation ) Progressive neurological chronic , progressive , debilitate condition ( e.g. , dementia ) Nonambulatory Life expectancy le 160 day , per treat oncologist Current suicide risk sufficient preclude treatment outpatient basis Chronic inflammatory autoimmune disorder ( e.g. , rheumatoid arthritis , lupus )</criteria>
	<gender>Female</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>psychological intervention</keyword>
	<keyword>breast cancer</keyword>
	<keyword>gynecologic cancer</keyword>
</DOC>